Malvern Instruments will demonstrate NanoSight Nanoparticle Tracking Analysis (NTA) at BioNanoMed 2014, the 5th International Congress on Nanotechnology, Medicine and Biology, which takes place in Krems, Austria from 26 – 28 March. A specialist from the company will also make a 10-minute presentation as part of the business sessions held alongside the conference.
The acquisition of NanoSight in September 2013 has extended Malvern’s range of analytical solutions for characterization at the nanoscale, with NTA ideally complementing the company’s Zetasizer Nano, Archimedes and Viscotek SEC systems.
NanoSight Nanoparticle Tracking Analysis detects and visualizes populations of nanoparticles in liquids down to 10 nm, dependent on the material, determining concentration and measuring the size of each particle from direct observations of diffusion. It does this with high resolution, in real time and with minimal sample preparation. Additionally, a fluorescence mode differentiates suitably-labelled particles within complex background suspensions. This real-time data gives insight into the kinetics of protein aggregation and other time-dependent phenomena in a qualitative and quantitative manner.
Key conference topics at BioNanoMed 2014 include: Novel Nanomedical Solutions - Advances in Nanomedicine; Nanomaterials for Biomedical Applications; Nano-Oncology: Diagnostic, Drug Delivery and Therapy; and NanoPharmaceuticals. Themed sessions cover: Nano-Bio-Sensing: New Sensing Approaches, Visions and Perspectives in Diagnosis and Therapy; Nano-Imaging Technologies in Medicine; and NanoSafety: Innovation-Enabler for Nanomedicine
To find out how Malvern’s extensive analytical solutions for characterization at the nanoscale can support your biomedical research, talk to the company specialists at BioNanoMed 2014, or visit http://www.malvern.com/nanoparticles
Malvern, Malvern Instruments and NanoSight are registered trademarks of Malvern Instruments Ltd